James Gammie is the surgical lead and co-director for the Johns Hopkins Heart and Vascular Institute and cardiac surgeon-in-chief for the Johns Hopkins Health System. With over 23 years of experience in cardiothoracic surgery, Dr. Gammie joined Johns Hopkins after serving as chief of the division of cardiac surgery at the University of Maryland Medical Center from 2012 to 2021. Dr. Gammie graduated from Brown University with a degree in biochemistry, and received his medical degree from the University of Massachusetts Medical School. Dr. Gammie trained in both general and cardiothoracic surgery at the University of Pittsburgh School of Medicine. His clinical and research efforts are focused on decreasing the mortality and morbidity of valve disease and improving the surgical treatment of mitral valve and other structural heart diseases. He performs over 225 mitral valve operations and interventions per year, and leads a cardiac surgery team that performs more than 1,200 cardiac operations annually. He is recognized by the Mitral Foundation and the American Heart Association as one of less than 25 reference surgeons in the U.S. for his experience in mitral valve repair and excellent patient outcomes. Dr. Gammie has a strong interest in all aspects of heart valve disease, and has published more than 200 peer-reviewed contributions in leading specialty journals including The New England Journal of Medicine, the Journal of Thoracic and Cardiovascular Surgery and Circulation. He has served as a deputy editor for The Annals of Thoracic Surgery and as chair of the Access and Publications Committee of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. He serves on the steering committee of the NHLBI-sponsored Cardiothoracic Surgery Trials Network, and led the protocol development committee of a worldwide randomized tricuspid valve surgery trial. He is a member of the Halsted Society and the 21st Century Cardiothoracic Surgical Society. In 2011, Dr. Gammie was awarded the Johns Hopkins/University of Maryland Alliance for Science and Technology Development BioMaryland LIFE Prize, and he was named Entrepreneur of the Year at the University of Maryland Baltimore in 2014. He is the inventor of a novel transseptal catheter designed to simplify transcatheter cardiac procedures, and founded a commercial company to commercialize the device. With 20 issued or submitted patents, he continues to innovate in the mitral valve space, and recently published the world’s first clinical experience with a novel surgical repair for secondary mitral valve regurgitation, which was developed in his laboratory: mitral valve translocation. From 2016–2021, Dr. Gammie was consistently named a Top Doctor by Baltimore magazine, and in 2018 he received the Golden Apple Teacher of the Year award. Dr. Gammie is rated as an Elite provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Mitral Valve Prolapse, Embolectomy, and Heart Bypass Surgery.

Susie Hong is a Cardiologist in Baltimore,, Maryland. Dr. Hong is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. Her top areas of expertise are Mitral Valve Regurgitation, Familial Ventricular Tachycardia, Necrosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Robert Hood is a Cardiologist in Baltimore,, Maryland. Dr. Hood is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Familial Ventricular Tachycardia, Necrosis, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Robert Benitez is a Cardiologist in Baltimore, Maryland. Dr. Benitez is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Mitral Valve Regurgitation, Necrosis, Cardiogenic Shock, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Chetan Pasrija, M.D. is a cardiothoracic surgeon in Baltimore, Maryland. He is an assistant professor of surgery at the Johns Hopkins University School of Medicine. Dr. Pasrija specializes in heart and lung transplantation, aortic surgery, and the surgical treatment of ischemic heart disease. He also has a particular interest in chronic thromboembolic pulmonary hypertension. He has published extensively on the topics of heart and lung transplant, massive pulmonary embolism, chronic thromboembolic pulmonary hypertension, and minimally invasive left ventricular assist device implantation. As a trainee, Dr. Pasrija was heavily involved with the surgical implantation and postoperative management of the first cardiac xenotransplant performed in the world at the University of Maryland. During his time as faculty at Vanderbilt University, he was a part of one of the largest heart and lung transplant programs in the United States. This included significant involvement with cutting-edge technologies to expand the donor pool, including normothermic regional perfusion and the Transmedics Organ Care System. Dr. Pasrija was co-surgeon in a combined heart-lung transplant with a groundbreaking 9.5 hour period of time without any blood flow using a novel 10⁰C cooler. He has also performed heart transplants with travel as far as Puerto Rico. Outside of transplantation, Dr. Pasrija is a high-volume cardiac surgeon, with an interest in complex open and endovascular aortic surgery. He performed the first ascending stent in the state of Tennessee, as well as the first total arch replacement without cooling the patient’s body in Tennessee using the Thoraflex device. He earned his Bachelor of Science Degree in Bioengineering at the University of Maryland and his Medical Degree at the University of Maryland School of Medicine. He completed an Integrated Cardiothoracic Surgery residency at the University of Maryland. During his training, he spent time at Vanderbilt University to learn advanced heart failure techniques as well as time at the University of Toronto to learn advanced lung transplant and pulmonary thromboendartectomy techniques. Additionally, he has a Masters in Clinical Research from the University of Maryland. Outside of his clinical interests, Dr. Pasrija is an accomplished investigator. During his post-doctoral research fellowship, he received a competitive American Heart Association post-doctoral fellowship award in addition to institutional awards for excellence in research. His research efforts focus on improving donor preservation with novel perfusion and temperature techniques, improving donor evaluation methods, and establishing novel immunologic therapies for transplant tolerance. Dr. Pasrija is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Mitral Valve Regurgitation, Aortic Valve Stenosis, Aortic Dissection, Embolectomy, and Heart Transplant.

Stephen Gottlieb is a Cardiologist in Baltimore,, Maryland. Dr. Gottlieb is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Heart Failure, Cardiomyopathy, Apoplexy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Ghoreishi is an internationally recognized expert. He brings exceptional skill in open and endovascular aortic repair, including aortic valve repair, Ross operation, valve sparing aortic root repair, innovation in minimally invasive techniques for aortic aneurysm repair, endovascular repair of high risk patients with acute type A or type B aortic dissection, and first-in-human procedures such as the Endo-Bentall repair for aortic dissection. His clinical leadership and innovation have drawn national and international referrals and advanced standards of care in this challenging field. Dr. Ghoreishi has served as Principal Investigator on several federally funded studies through the National Heart, Lung, and Blood Institute (NHLBI) and is a frequent contributor to national guidelines and surgical education symposia. Dr. Ghoreishi is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Aortic Dissection, Cystic Medial Necrosis of Aorta, Thoracic Aortic Aneurysm, Embolectomy, and Heart Bypass Surgery.

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Rani Hasan is an Interventional Cardiologist in Baltimore, Maryland. Dr. Hasan is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

"Originally from Wisconsin, Dr. Czarny attended the University of Wisconsin where he majored in molecular biology. After medical school at the Johns Hopkins University School of Medicine, he completed an internal medicine residency at the Brigham and Women’s Hospital in Boston followed by cardiovascular disease, interventional cardiology, and structural heart disease fellowships at Johns Hopkins. Currently, he is a faculty member in interventional cardiology and performs heart catheterizations and coronary artery stenting for patients with stable coronary artery disease (CAD) and myocardial infarctions (""heart attacks"") at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. He is also a member of the Structural Heart Disease team and performs minimally invasive, catheter-based treatments for structural heart disease at the Johns Hopkins Hospital including transcatheter aortic valve replacement (TAVR) for aortic valve stenosis, valve repair/replacement procedures for mitral valve regurgitation and stenosis, patent foramen ovale closure, atrial septal defect closure, alcohol septal ablation for hypertrophic cardiomyopathy, and left atrial appendage occlusion with the Watchman(TM) device. He sees patients in his structural heart disease clinics at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. Dr. Czarny's research interests include the safety of cardiac stenting at hospitals without cardiac surgery backup and outcomes of catheter-based structural heart procedures.". Dr. Czarny is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Jennifer S. Lawton, M.D., is the Richard Bennett Darnall Professor of Surgery and chief of the Johns Hopkins Division of Cardiac Surgery, as well as director of the Cardiac Surgery Research Laboratory. Dr. Lawton’s clinical area of focus is adult cardiac surgery. She also leads the division’s residency education program, and conduct research in myocyte volume regulation and ATP-sensitive K channels. She has held important leadership roles in several organizations, including chair of the surgery study section of the American Heart Association, vice-chair of the ACGME residency review committee, and president of the Women in Thoracic Surgery. Lawton’s achievements also include 81 peer-review publications, 7 book chapters, and 18 abstracts. She has delivered over 50 invited lectures. Dr. Lawton is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. Her top areas of expertise are Heart Tumor, Aortic Dissection, Atrial Myxoma, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Dr. Katherine Wu is a general cardiologist for the Heart and Vascular Institute at Johns Hopkins Medicine with an interest in caring for patients with cardiomyopathies, coronary artery disease, and valvular heart disease as well as those interested in cardiovascular prevention. She has additional expertise in non-invasive cardiology imaging techniques. Dr. Wu received her medical degree from the University of Pennsylvania Health System School of Medicine, and completed her residency and a cardiology fellowship at the Johns Hopkins University School of Medicine. She joined the School of Medicine faculty in 2000. Dr. Wu's research interests include improving individualized risk prediction for sudden cardiac death and heart failure by developing and validating methods that incorporate novel cardiac imaging indices. Her lab is funded by the NIH/NHLBI. Dr. Wu has more than 70 peer-reviewed publications and serves on the editorial board of the Journal of Cardiovascular Magnetic Resonance and Circulation Cardiovascular Imaging and is a standing member of the NIH Clinical and Integrative Cardiovascular Sciences Study Section. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. Her top areas of expertise are Cardiomyopathy, Atrial Fibrillation, Heart Attack, and Pulmonary Hypertension.

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Multifocal Atrial Tachycardia, Cardiac Ablation, and Tissue Biopsy.

Jelani Grant is a Cardiologist in Baltimore, Maryland. Dr. Grant is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Aortic Valve Stenosis, Heart Failure, Atherosclerosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Duke Cameron, M.D. is a cardiothoracic surgeon in Baltimore, MD. He is a professor of surgery at the Johns Hopkins School of Medicine. Dr. Cameron is world-renowned for his expertise in the surgical repair of the aorta. He is internationally recognized for his contributions to cardiac surgery, particularly aortic surgery for Marfan syndrome, Loeys-Dietz syndrome and other connective tissue disorders. He also specializes in mitral valve repair and adult congenital heart disease. His multiple academic contributions span the breadth of pediatric and adult cardiac surgery. Dr. Cameron is a graduate of Harvard College and Yale Medical School. He completed his general surgery training at Yale-New Haven Hospital and his cardiothoracic fellowship training at the Johns Hopkins Hospital. After his training, he remained on the faculty at Johns Hopkins. Dr. Cameron most recently served on staff at Massachusetts General Hospital before returning to Johns Hopkins. Dr. Cameron is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Aortic Dissection, Cystic Medial Necrosis of Aorta, Thoracic Aortic Aneurysm, Patent Foramen Ovale Repair, and Heart Valve Repair.

Gautam Ramani is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Baltimore, Maryland. Dr. Ramani is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cardiomyopathy, Embolectomy, and Aortic Valve Replacement. Dr. Ramani is currently accepting new patients.

Bradley Maron is a Cardiologist in Baltimore,, Maryland. Dr. Maron is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Glenn Whitman, M.D., joined the Johns Hopkins Division of Cardiac Surgery in 2009 as associate professor of surgery. His training began at the University of Pennsylvania, where he was a resident in surgery from 1979 to 1984. He then finished his general surgery training and then completed his training as a cardiothoracic surgeon at the University of Colorado. Thereafter, Dr. Whitman became an assistant professor at the University of Colorado and chief of cardiothoracic surgery at the Denver Veteran’s Administration Hospital, where he remained for two years. In 1990, he returned to his home city of Philadelphia, where he became chief of cardiac surgery at the Medical College of Pennsylvania, formerly Women’s Medical College, the first medical school in the United States to accept women. Dr. Whitman remained there for eight years before moving to the University of Maryland as chief of cardiac surgery. He has served as the director of transplantation and United Network for Organ Sharing representative at Temple University Hospital in Philadelphia, as well as its director of perioperative services, managing preadmission testing, the operating room, and the post-anesthesia care unit. In 2007, he left Temple for Thomas Jefferson Hospital, taking over the responsibilities of running the cardiac surgery intensive care unit. In summer 2009, he was returned to Baltimore to run the cardiac surgery intensive care unit and oversee the performance improvement/quality assurance program for cardiac surgery at Johns Hopkins. Dr. Whitman’s initial research interests were in cardiac ischemia-reperfusion injury and P31 nuclear magnetic resonance of cardiac bioenergetics, for which he received both National Institutes of Health and Department of Veterans Affairs funding. He has since become involved with quality outcome, and has presented at the American College of Surgeons and the Society of Thoracic Surgeons on the difficulties associated with performance improvement and quality assurance in the field of health care, particularly in the ICU. This past year, Dr. Whitman has stepped down from his role as the Chair of the Society of Thoracic Surgery Workforce on Critical Care, a role he had held since 2014. He continues to participate in the content of the Annual Meetings for the Society of Thoracic Surgery, The American Association of Thoracic Surgery, and The STS Fall Critical Care meetings as the Programmatic Co-Chair for Perioperative Care. This past year he has participated in two major consensus statements on postcardiotomy shock (see below) and low ejection fraction CABG patients (awaiting review). 2020 EACTS/ELSO/STS/AATS ExpertConsensus on Post-CardiotomyExtracorporeal Life Support in Adult Patients Ann Thorac Surg 2012;111:327-69. Dr. Whitman is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Cardiogenic Shock, Restrictive Cardiomyopathy (RCM), Hemolysis, Heart Bypass Surgery, and Heart Transplant.

Dr. Michael Kelemen is a general cardiologist for the Johns Hopkins Heart and Vascular Institute in the Department of Medicine. His research in cardiac rehabilitation demonstrated the power of exercise as a treatment for hypertension, high cholesterol, and recovery from cardiac events. Dr. Kelemen is an associate professor of medicine in the Johns Hopkins School of Medicine. Dr. Kelemen received his medical degree from the University of Pennsylvania Health System School of Medicine. He completed his residency in medicine at University Hospitals of Cleveland, and pursued cardiology fellowships at the University of California, San Francisco School of Medicine and at the Wyman Park Health System in Baltimore. Dr. Kelemen is active in community health issues, having served on the boards of the Health Alliance and The Horizon Foundation, which provide medical and mental health services to underserved populations. As the founding medical director of the Prescribed Active Cardiac Exercises (PACE) program at Catonsville Community College in 1976, he performed the research that demonstrated the benefits of exercise for cardiac patients. Dr. Kelemen is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. His top areas of expertise are Heart Attack, Apoplexy, Postural Orthostatic Tachycardia Syndrome (POTS), and Brugada Syndrome.

Dr. Allison Hays is a general cardiologist and Medical Director of Echocardiography Programs at the Johns Hopkins Hospital. She is also an assistant professor at the Johns Hopkins University School of Medicine. Dr. Hays graduated from Stanford University with degrees in biology and English. She received her medical training at the Columbia University College of Physicians and Surgeons and did her residency at the New York Presbyterian Hospital at Columbia. Dr. Hays pursued cardiology fellowships at New York University Medical Center and at the Johns Hopkins University School of Medicine. Dr. Hays studies ways to use noninvasive imaging to detect cardiovascular disease. She has advanced multimodality imaging training from Johns Hopkins and attends in the Adult Echocardiography Lab at Johns Hopkins Hospital. In terms of research, she uses Cardiac MRI as a tool to study coronary and systemic endothelial function. Dr. Hays is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. Her top areas of expertise are Familial Ventricular Tachycardia, Cardiomyopathy, COVID-19, Heart Attack, and Tissue Biopsy.